Sosei Group Corporation

Sosei Group Corporationverified

SOLTF

Price:

$8.052

Market Cap:

$112.01B

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboratio...[Read more]

Industry

Biotechnology

IPO Date

2013-09-04

Stock Exchange

PNK

Ticker

SOLTF

The ROE as of November 2024 (TTM) for Sosei Group Corporation (SOLTF) is -15.15%

According to Sosei Group Corporation’s latest financial reports and current stock price. The company's current ROE is -15.15%. This represents a change of 282.41% compared to the average of -3.96% of the last 4 quarters.

Sosei Group Corporation (SOLTF) Historical ROE (quarterly & annually)

How has SOLTF ROE performed in the past?

The mean historical ROE of Sosei Group Corporation over the last ten years is 2.26%. The current -15.15% ROE has changed -770.27% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's ROE was at its highest in in the June 2016 quarter at 37.94%. The ROE was at its lowest in in the March 2016 quarter at -16.26%.

Quarterly (TTM)
Annual

Average

2.26%

Median

2.30%

Minimum

-16.26%

Maximum

33.42%

Sosei Group Corporation (SOLTF) ROE by Quarter and Year

Discovering the peaks and valleys of Sosei Group Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 33.42%

Minimum Annual Increase = -1732.88%

Minimum Annual ROE = -16.26%

Quarterly (TTM)
Annual
YearROEChange
2023-10.77%-1732.88%
20220.66%-62.74%
20211.77%-37.32%
20202.82%-11.12%
20193.18%-119.54%
2018-16.26%-148.65%
201733.42%-599.90%
2016-6.68%-274.13%
20153.84%-63.89%
201410.63%-204.04%

Sosei Group Corporation (SOLTF) Average ROE

How has SOLTF ROE performed in the past?

The current ROE of Sosei Group Corporation (SOLTF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-2.78%

5-year avg

-0.47%

10-year avg

2.26%

Sosei Group Corporation (SOLTF) ROE vs. Peers

How is SOLTF’s ROE compared to its peers?

Sosei Group Corporation’s ROE is greater than Gain Therapeutics, Inc. (-203.91%), greater than BioVie Inc. (-188.95%), greater than IN8bio, Inc. (-197.15%), greater than NewAmsterdam Pharma Company N.V. (-53.79%), greater than Cue Biopharma, Inc. (-156.38%), greater than uniQure N.V. (-188.82%), greater than Rocket Pharmaceuticals, Inc. (-62.62%), greater than Rhythm Pharmaceuticals, Inc. (-369.26%), greater than Solid Biosciences Inc. (-58.75%), greater than MeiraGTx Holdings plc (-80.95%), greater than Apellis Pharmaceuticals, Inc. (-103.92%), greater than Blueprint Medicines Corporation (-47.66%), greater than Karuna Therapeutics, Inc. (-25.23%), greater than Mirati Therapeutics, Inc. (-40.45%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than VectivBio Holding AG (-56.92%), less than AVROBIO, Inc. (29.68%), greater than Zura Bio Limited (-39.61%), greater than Elevation Oncology, Inc. (-59.73%), greater than Hepion Pharmaceuticals, Inc. (-505.74%),

Build a custom stock screener for Sosei Group Corporation (SOLTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sosei Group Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sosei Group Corporation (SOLTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sosei Group Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Sosei Group Corporation's ROE?

How is the ROE calculated for Sosei Group Corporation (SOLTF)?

What is the highest ROE for Sosei Group Corporation (SOLTF)?

What is the 3-year average ROE for Sosei Group Corporation (SOLTF)?

What is the 5-year average ROE for Sosei Group Corporation (SOLTF)?

How does the current ROE for Sosei Group Corporation (SOLTF) compare to its historical average?